Zobrazeno 1 - 10 of 38 pro vyhledávání: '"Fumihiro Takahashi"'
4
Slowing the loss of physical function in amyotrophic lateral sclerosis with edaravone: Post hoc analysis of ALSFRS‐R item scores in pivotal study MCI186 ‐19
Autor: Koji Takei, Erik P Pioro, Fumihiro Takahashi, Stephen Apple, Benjamin Rix Brooks, Jeffrey Zhang, Jonathan S. Katz
Publikováno v: Muscle & Nerve. 65:180-186
Introduction Phase 3 study MCI186-19 demonstrated less loss of physical function with edaravone versus placebo, as measured by the revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R) total score. A 1-point drop in an individual A
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fc03e13f12153605f2d0c575f963c75
https://doi.org/10.1002/mus.27467
Zobrazit plný text záznamu
6
Associations between urate levels and amyotrophic lateral sclerosis functional score with edaravone treatment: Post hoc analysis of studies MCI186-16, MCI186-17, and MCI186-19
Autor: Fumihiro, Takahashi, Osamu, Kano, Yoshito, Nagano, Takatomo, Yoneoka, Sally, Nelson, Yoshiteru, Ushirogawa
Publikováno v: MusclenerveREFERENCES. 66(5)
Edaravone in amyotrophic lateral sclerosis (ALS) was analyzed in two phase 3 studies (MCI186-16 and MCI186-19). Those trials enrolled patients with Japanese ALS severity grades 1 and 2 (less severe ALS), but many patients progressed to grades 3 and 4
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::18ff6556a6207c4658b0ef304b1733a3
https://pubmed.ncbi.nlm.nih.gov/36054038
Zobrazit plný text záznamu
7
Associations between the ALSFRS-R score and urate levels during 12 months of edaravone treatment for amyotrophic lateral sclerosis: Post hoc analysis of ALSFRS-R scores in clinical studies MCI186-16, MCI186-17, and MCI186-19
Autor: Fumihiro, Takahashi, Osamu, Kano, Yoshito, Nagano, Takatomo, Yoneoka, Sally, Nelson, Yoshiteru, Ushirogawa
Publikováno v: MusclenerveREFERENCES. 66(5)
In this study we examined the relationship between urate levels at baseline and functional change measured by the Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R) total score after edaravone treatment.Data from the edaravone t
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::aa44adc6cf01a0420b84a4cd1de826f6
https://pubmed.ncbi.nlm.nih.gov/36053970
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje